PF-05231023
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for PF-05231023, covering 2014-09-17 to 2016-11-18. Get the full timeline:
Most recent: Clinical Trial Update: Safety And Tolerability Of Escalating Intravenous Doses Of PF-05231023 In Adult Subjects With Type 2 Diabetes [Phase 1]